Try our Advanced Search for more refined results
Life Sciences - October, 2011
174 articles
- Calif. Court Tosses Pay-For-Delay Suit Over Bayer's Cipro
- Amylin Can't Block Lilly's Rival Drug Sales: 9th Circ.
- Cephalon Patent Found Invalid In Pay-For-Delay Case
- Insured Can't Appeal Cancer Coverage Ruling: Judge
- AstraZeneca, Pozen Want Generic Arthritis Drug Blocked
- Medical Device Preemption Case Rejected By High Court
- Obama Orders FDA Crackdown On Drug Shortages, Gouging
- Fed. Circ. Won't Rethink BD Syringe Patent Fight
- Divisive Teva-Merck IP Ruling Stays Out Of Supreme Court
- High Court Vacates Generics Preemption Ruling
- Momenta Gets Rivals' Sale Of Generic Lovenox Barred
- Pfizer Failed To Warn Of Zoloft Birth Defect Risks: Suits
- Ex-Ky. Judge Disbarred Over $126M Fen-Phen Fees
- Sun Capital's $36.6M Bid For Body Armor Co.'s Assets OK'd
- Pharmacies Bring Pfizer-Wyeth Merger Suit To High Court
- Coventry Nears Copay Case Deal On Eve Of Trial
- County Can't Pursue Own Avandia False Ad Claims: Judge
- HealthSpring Investor Tries To Halt Cigna Purchase
- Patterns In Post-Adjudication Of Infringement Damages
- Bristol-Myers Can't Shake Suit Over Kickbacks Scheme
- Yaz MDL Plaintiffs Say FDA Should See Confidential Docs
- Yaz, Other Birth Control Drugs Boost Blood Clot Risk: FDA
- BioMed Secures Tenant For I-270 Office
- Jury Awards Novozymes $18M In IP Fight With DuPont Unit
- Mass. REIT Breaks Ground On $500M Alexandria Center
- Case Study: Merck V. Garza
- McKesson Pays $82M To End Drug Price Inflation Suit
- Astellas Drug Reps Get Initial Class Cert. In OT Case
- Bristol-Myers Faces Italian Scrutiny Over '90s Ops
- Barclays PE Snaps Up Swiss-Owned Chemical Co.
- Medtronic Catheter Side Effects Are Cause For Concern: US
- Investor Sues Google Directors Over Online Drug Sales
- China's Global Pharm Scores $15M To Fund Future Buys
- You Cannot Sue For What They Cannot Do
- Contractor For 9/11 Lighting Tribute Seeks Ch. 11
- Merchant & Gould Adds Sutherland IP Pro To Atlanta Office
- Danisco Fails To Prove Novozymes Ethanol IP Invalid
- Olympus Head Steps Down Amid Merger Fee Scandal
- Stikeman Guides Cardinal Health's $162M Futuremed Buy
- GSK Hid Morning Sickness Drug's Birth Defect Risks: Suit
- 8th Circ. Won't Revive Minn. Prempro Suits
- Eli Lilly Settles Suit Over Generic Prozac Suicide Risk
- Omnicare Faces Fresh Suit Over Alleged Medicare Fraud
- Novartis Unit Subpoenaed In HHS Fraud Investigation
- Ex-Orrick Atty To Launch Marten Law Office In SF
- Olympus Struggles To Survive Merger Fee Scandal
- Body Armor Co. Settles Defective Vest Claims For $1M
- The Curious Case Of Urology Of Central Pa.
- Eli Lilly Pulls 'Ineffective' Sepsis Drug Xigris
- Penn Medicine, REIT Invest $72M In Hospital High-Rise
- Drug Cos. Made Record Pay-For-Delay Deals In 2011: FTC
- Accel-KKR Invests In Scientist Networking Co. Expansion
- Amgen To Pay $780M To Settle Drug Sales Suits
- FDA Raises Doubts Over Insufficient AtriCure Trial
- Software Co. Investors Can't Revive Suit Over Oracle Buy
- Bristol-Myers, Novartis Settle With Teva Over HIV Drug IP
- Biotronik Can't Seek $100M From J&J Over Stents: Judge
- Chantix No Riskier Than Nicotine Patch, Gum: Studies
- Olympus Faces FBI Probe Over $687M Merger Advisory Fee
- HIPAA — Paper Law No More
- 9th Circ. Backs Insurer's Win In Ventana IP Defense Row
- South Korea Fines GSK $2.6M Over Pay-For-Delay Deal
- Alkermes, Jazz Aim To Block Torrent's Generic Luvox
- Cigna Buys HealthSpring For $3.8B With Davis Polk Help
- Wyeth Shareholders Seek Class Cert. In Pristiq Suit
- Actavis, Mylan Can Use Expert's Word In Heart Drug MDL
- MillerCoors, Nestle, Insurers Sued Over Navy Tech IP
- DLA Piper Life Sciences Partner Jumps To Fenwick
- Winston & Strawn Helps AAR Land Teleflex Units For $280M
- AMAG Shareholders Reject $268M Allos Merger
- Pros And Cons Of A CMS-FDA Parallel Review Program
- EU Scrutinizes J&J, Novartis Generic Painkiller Deals
- Systemic Discrimination? Let The Statistics Talk
- Pfizer Unit Off The Hook In Prempro Breast Cancer Case
- Abbott, Fournier Settle With Impax Over Generic Trilipix
- Fla. Appeals Court Nixes Ex-Hospital Chief's $10M Libel Win
- Pfizer Pays $14.5M To End Whistleblowers' FCA Suit
- Investor Says K-V Lied About Pregnancy Drug's Prospects
- Wyeth Sued Again Over Effexor Generics Delays
- Case Study: FTC V. Lundbeck
- Novartis Stuck With Sanctions In Bone Drug MDL
- Concrete Buyers Want $18M In Antitrust Deals OK'd
- FDA Deems CareFusion Ventilator Defect High-Risk
- Novo Ramps Up Prandin IP Battle With Sandoz Suit
- Miller & Chevalier Adds Ex-Baxter Atty
- Abbott Labs Splits In Bid To Drive Growth
- Warner Chilcott Hits Watson With Atelvia Patent Suit
- Judge Tosses Elan Shareholder Suit Over $1B J&J Deal
- EU High Court Bans Patents For Embryonic Stem Cells
- Abbott, Lilly Fight Sales Reps' OT Claims In 7th Circ.
- FDA Warns GSK Over Manufacturing Violations In UK
- FDA Chemist Pleads Guilty To $4M Insider Trading Plot
- Fed. Circ. Nixes Apotex $108M Interest Payout Over Plavix
- Floundering Graceway Wins OK For Asset Auction
- Pfizer Wins Attys' Fees From Teva In Viagra Patent Row
- Severance In Multiplaintiff Pharmaceutical Cases
- Conceptus Scores $18.8M Victory In Hologic Patent Fight
- Ex-Alfacell Exec's Securities Suit Gets The Boot
- Alcon Sues Generics Maker Over Nasal Spray Patent
- Ametek Acquires Privately Held Eye Care Co. For $150M
- Bausch & Lomb, Insurer Settle Infection Coverage Row
- Davis Polk Advises Roche In $230M Deal To Buy Anadys
- GSK Settles Direct Buyers' Wellbutrin Claims For $49M
- Innovative Corporate Counsel: Elpidio 'PD' Villarreal
- J&J Unit Bests Suit Over Levaquin Injuries
- Teva, Cephalon Win EU Antitrust OK For $6.8B Tie-Up
- SEC's Headache Over Conflict Mineral Rules Won't Go Away
- Pharma Co. Wants Ropes & Gray Atty Tossed From IP Suit
- Sens. Target FDA Regs To Speed Medical Device Review
- Amgen Asks 9th Circ. To Undo Shareholder Class Cert.
- Trust Can't Boot Abbott's Humira Patent Challenge
- PPD Investor Sues Over $4B Carlyle, Hellman Buyout
- Noven Tries To Block Watson's Generic Daytrana
- Allos Settles Investor Suit Over $686M AMAG Tie-Up
- AstraZeneca, Sun Pharma Settle Over Nexium Generic
- Centurion Shores Up Biotech Outfit With $10M Investment
- Siemens, U. Of Neb. Settle Lab Test Patent Suit
- Innovative Corporate Counsel: Amy Schulman
- Judge Pares Solvay Drug Marketing Scheme Suit
- Antitrust Group Urges 8th Circ. To Rehear FTC Drug Suit
- Case Study: PharmAthene V. SIGA
- Innovative Corporate Counsel: Marla Persky
- Bayer, Merial Hit With $32B Class Suit Over Flea Meds
- Allergan Sues Hi-Tech Over Pinkeye Drug Patents
- Teva, Baxter Told To Pay $104M In Propofol Hepatitis Case
- Pfizer, Actavis End Patent Fight Over Generic Lipitor
- Google, TPG, Others Invest $15M In DNA Data Firm
- SciClone Shells Out $2.5M To Investors Amid FCPA Probes
- Purdue Sues Ranbaxy Again Over Generic OxyContin
- Applied Scores Victory In Covidien Surgical Tool IP Fight
- FDA Tweaks Cancer Drug Warnings Over Hypertension Risk
- Amylin Calls For Lilly Marketing Injunction In 9th Circ.
- Seattle Genetics Insider's Brother Gets 18 Months
- Investor Says Stereotaxis Hid Problems With Products
- FCPA Lawsuits — Not Just For The Government
- Drugmaker Takes FDA Generics Rule Fight To DC Circ.
- Teva Must Surrender Generics To Get Cephalon: FTC
- Momenta Stops Rivals' Generic Lovenox Launch For Now
- Gores' $30M Bid Leads Point Blank Ch. 11 Sale
- Simpson, Kirkland Aid Investors In $1.6B KCI Notes Deal
- Fulbright Securities Atty Jumps To Greenberg
- HHS Urges DC Circ. To Keep Ban On OxyContin Misbranders
- Baxter To Exit Drug Price Inflation MDL For $30M
- FTC Speeds Approval Process For Divestiture Order Tweaks
- The Downside Of Tort Reform
- Corporate Counsel Beware: Limits Of 'No Contact Rule'
- Pfizer Sues Watson Over Embeda Generic
- A Creative Fix To A Medical Monopoly Problem
- SEC Sues Ex-Hansen Execs Over Fake Catheter Sales
- Krill Oil Extractor Neptune Sues Rivals Over New Patent
- Innovative Corporate Counsel: Moze Cowper
- Creabilis Raises $20M To Develop Dermatology Drugs
- AstraZeneca, Accord Settle Seroquel XR Patent Spat
- Web Pharmacies Sold Generics Under Celgene Marks: Suit
- Generics Cos. Rip AstraZeneca's Crestor IP In Fed. Circ.
- Ricky Nelson's Estate Sues Capitol Over Royalties
- Questioning US Antitrust Liability Of Foreign Defendants
- Relpax Patent Fight Revived After Stalled Settlement
- Impax Suit Against Pfizer Denied In IP Fight Over Detrol
- Jury Awards Man $48M For Extreme Reaction To Motrin
- Elan Again Beats Claims It Hid Drug Trial Data
- Pfizer Sued By Drugmaker Over Yanked Feed Additive
- Mispackaged Birth Control Pills Caused Pregnancy: Suit
- Genzyme Gets Rival Pain Med Barred For Now In IP Row
- Watchdog Releases Contractor Misconduct Database
- FDA Pitches New Transparency, Social Media Plans
- Tucker Ellis Grabs 2 Jones Day Litigators In Cleveland
- 7th Circ. Overturns Affymax Foreign Patent Ruling
- Bringing ANDA Litigation To East Texas
- Shareholder Suit Over J&J Recall, Kickback Woes Tossed
- Jury Lets Merck Off Hook In Fosamax Bellwether Suit
- Mylan Can't Get Top Court Review Of $76M Antitrust Ruling
- Carlyle, Hellman To Take PPD Private For $3.9B
- Proskauer Says J&J Heir's Malpractice Suit Time-Barred